Evolus Inc (EOLS) support and resistance · rev $266.3M
Evolus Inc (EOLS) is a drug manufacturers - specialty & generic company listed on US.
This page maps Evolus Inc (EOLS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported EOLS revenue for 2024-12-31 was $266.3M. Net income was -$50.4M. Revenue was up 31.8% from 2023-12-31 to 2024-12-31. EOLS currently screens at market cap $597.0M.
EOLS currently screens at market cap $597.0M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new EOLS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the EOLS quote page for the session range and the stock page for the full model.
Not investment advice.